Summit Therapeutics
SMMT
SMMT
100 hedge funds and large institutions have $87.7M invested in Summit Therapeutics in 2023 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
15% less call options, than puts
Call options by funds: $312K | Put options by funds: $366K
Holders
100
Holding in Top 10
–
Calls
$312K
Puts
$366K
Top Buyers
| 1 | +$17.4M | |
| 2 | +$11.6M | |
| 3 | +$5.35M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.99M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.42M |
Top Sellers
| 1 | -$3.29M | |
| 2 | -$1.98M | |
| 3 | -$1.4M | |
| 4 |
Jane Street
New York
|
-$988K |
| 5 |
Two Sigma Investments
New York
|
-$838K |